Amanote Research

Amanote Research

    RegisterSign In

A Comparison of Beta Adrenergic Blocking Drugs in the Treatment of Hypertension

Postgraduate Medical Journal - United Kingdom
doi 10.1136/pgmj.50.583.253
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

May 1, 1974

Authors
T. O. MorganS. N. AnavekarJ. SabtoW. J. LouisA. E. Doyle
Publisher

BMJ


Related search

Beta-Adrenergic Blocking Drugs and Thyroid Function.

BMJ
1977English

Beta Adrenergic Blocking Drugs and the Borg Rating Scale of Perceived Exertion.

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
1997English

Can Insulin-Treated Diabetics Be Given Beta-Adrenergic Blocking Drugs?

BMJ
1980English

Can Insulin-Treated Diabetics Be Given Beta-Adrenergic-Blocking Drugs?

BMJ
1980English

Hemodynamic Effects of Tilisolol, a New .BETA.-adrenergic Blocking Agent With Vasodilating Property, and Doxazosin, a New .ALPHA.-adrenergic Blocking Agent, in Essential Hypertension.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1988English

Alpha- And Beta-Adrenergic Receptor Blockade in the Treatment of Hypertension.

Heart
Cardiovascular MedicineCardiology
1974English

The Effect of Alpha and Beta Adrenergic Blocking Drugs Upon the Aversive Threshold of Rats

Physiological Psychology
1975English

The Paradox of Beta-Adrenergic Blockade in Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
1968English

Letter: Oculocutaneous Reactions in Beta-Blocking Drugs.

BMJ
1975English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy